Parallel Bio
PrivateLast Round
Series A
Jun 12, 2025
Total Funding Raised
$25.43M
Company Overview
Parallel Bio is a biotechnology company that pioneers human-first drug discovery by combining immune organoids with artificial intelligence. Its platform, referred to as "Clinical Trial in a Dish," replicates the human immune system to test the safety and efficacy of new immunotherapies on diverse human models at the earliest stages of development. The company partners with pharmaceutical firms to more accurately predict drug success, aiming to significantly reduce the high failure rates, costs, and long timelines associated with traditional animal testing. Parallel Bio has raised nearly $30 million in funding, including a $21 million Series A round in June 2025, to scale its platform and expand its partnerships.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Parallel Bio Comps
Public and private peers based on sector, stage, and business model.
Parallel Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 12, 2025 | ||||
| Seed | Dec 20, 2022 | ||||
| Seed | Sep 1, 2021 |
Parallel Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Refactor Capital | Seed |
| Atypical | Series A |
| Amplo | Series A |
| Metaplanet Holdings | Series A |
| Breakout Ventures | Seed |
| Humba Ventures | Series A |
| Y Combinator | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Data supports partner's FDA filing for Phase 1 trial.
- Mar 1, 2026
Executed 10 pharma contracts with strong year-over-year revenue growth.
Parallel Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Parallel Bio's valuation, stock price, and market status.
